Last updated on August 2018

Natural History of the Progression of Choroideremia Study


Brief description of study

Choroideremia (CHM) is a rare, X-linked recessive, degenerative disease of the retina which begins in childhood with loss of night vision and gradually progresses to legal blindness by the fifth decade. There are no approved treatements for CHM and the disease is poorly characterised given its rare nature and scarscity of available data. The objective of this study is to collect natural history data from a large cohort of CHM patients in order to evaluate possible efficacy measures that could be utilised in future interventional trials of novel therapies.

Clinical Study Identifier: NCT03359551

Find a site near you

Start Over

Study Site

Los Angeles, CA United States
  Connect »

Study Site

Miami, FL United States
  Connect »

Study Site

Baltimore, MD United States
  Connect »

Study Site

New York, NY United States
  Connect »

Study Site

Portland, OR United States
  Connect »

Study Site

Dallas, TX United States
  Connect »

Study Site

Madison, WI United States
  Connect »

Study Site

São Paulo, Brazil
  Connect »

Study Site

Québec, Canada
  Connect »

Study Site

Vancouver, Canada
  Connect »

Study Site

Helsinki, Finland
  Connect »

Study Site

Montpellier, France
  Connect »

Study Site

Tübingen, Germany
  Connect »

Study Site

Nijmegen, Netherlands
  Connect »

Study Site

London, United Kingdom
  Connect »

Study Site

Manchester, United Kingdom
  Connect »

Study Site

Oxford, United Kingdom
  Connect »